The fight for two tumor types is poised to intensify, with BioNTech lining up a challenge to AstraZeneca, while SynOx Therapeutics is planning to enter a market served by companie ...
Background: Survivors of cancer in adolescence and young adulthood are at increased risk for subsequent primary neoplasms, but studies using Canadian data are limited. We sought to quantify the risk ...
Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will present new research at the American Association for Cancer Research (AACR) Annual Meeting, highlighting ...
Morning Overview on MSN
Zeaxanthin may boost anti-tumor immune response in cancer care
Checkpoint inhibitors have transformed cancer treatment over the past decade, helping hundreds of thousands of patients by ...
Consumers can protect their skin from damaging ultraviolet (UV) light rays for as little as $40 a year—or as much as $1,400 a year—depending on how expensive a sunscreen they buy and how much of their ...
Morning Overview on MSN
One-shot vaccine injected into tumors shows promise for boosting survival
A single injection of a redesigned immune-stimulating antibody directly into a tumor was linked to shrinkage not only at the ...
Princeton researchers have revealed new links between high-fat diets and aggressive breast cancer, demonstrating the ...
The FDA has granted Fast Track Designation to CTIM-76, a claudin-6 (CLDN6) x CD3 T cell engaging bispecific antibody, for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results